CIK: 0001577524 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 23, 2018
Total Value ($000): $390,650 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 413,858 | $131,842 | 33.7% | $285.68 | +12.3% | COM | 09062X103 |
| — | BIOVERATIV INC | 1,165,000 | $62,816 | 16.1% | $53.92 | — | COM | 09075E100 |
| — | MEDICINES CO | 1,922,000 | $52,547 | 13.5% | $29.43 | — | COM | 584688105 |
| INVA | INNOVIVA INC | 3,660,705 | $51,945 | 13.3% | $11.14 | +19.7% | COM | 45781M101 |
| — | ALLERGAN PLC | 257,300 | $42,089 | 10.8% | $163.58 | — | SHS | G0177J108 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,650,000 | $24,733 | 6.3% | $13.06 | 0.0% | COM CLA | 46333X108 |
| — | INTERCEPT PHARMACEUTICALS INC | 182,300 | $10,649 | 2.7% | $58.41 | — | COM | 45845P108 |
| — | ACHILLION PHARMACEUTICALS INC | 2,500,000 | $7,200 | 1.8% | $4.26 | — | COM | 00448Q201 |
| — | NOVELION THERAPEUTICS INC | 1,025,000 | $3,198 | 0.8% | $8.42 | — | COM NEW | 67001K202 |
| — | APRICUS BIOSCIENCES INC | 1,447,906 | $2,664 | 0.7% | $1.30 | — | COM NEW | 03832V307 |
| ABBV | ABBVIE INC | 10,000 | $967 | 0.2% | $38.85 | +72.2% | COM | 00287Y109 |